9amHealth operates a virtual, whole-body cardiometabolic care programme for obesity, diabetes and heart conditions. Founded in 2021, the company combines a dedicated care team - obesity specialists, pharmacists, dietitians and behavioural health experts - with prescription medications delivered to the home, at-home lab tests, connected devices and unlimited specialist access through an app. Its technical work spans virtual care infrastructure, healthcare app development, connected health devices, at-home lab testing and chronic disease management.
The company reports measurable clinical outcomes from its members: a 17.6% weight reduction over 12 months for those on GLP-1s, a 2.8% reduction in A1c, and significant improvements in blood pressure. Data drawn from lab tests and connected devices feeds into personalised treatment plans, making engineering work central to how care is measured and adjusted.
9amHealth serves patients across 47 states and Washington, D.C. The stated philosophy is that chronic condition care should be affordable, accessible and kind; many staff have diabetes themselves or in their families. The care model treats conditions as connected rather than isolated and removes waiting rooms, pharmacy lines and restricted provider access.
